{"name":"Cttq","slug":"cttq","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Generic Zoledronic Acid","genericName":"Generic Zoledronic Acid","slug":"generic-zoledronic-acid","indication":"Metastatic bone disease in cancer patients","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Original Zoledronic Acid","genericName":"Original Zoledronic Acid","slug":"original-zoledronic-acid","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Generic Zoledronic Acid","genericName":"Generic Zoledronic Acid","slug":"generic-zoledronic-acid","phase":"marketed","mechanism":"Zoledronic acid inhibits osteoclast-mediated bone resorption by blocking farnesyl pyrophosphate synthase in the mevalonate pathway.","indications":["Metastatic bone disease in cancer patients","Multiple myeloma with bone involvement","Osteoporosis","Paget's disease of bone","Hypercalcemia of malignancy"],"catalyst":""},{"name":"Original Zoledronic Acid","genericName":"Original Zoledronic Acid","slug":"original-zoledronic-acid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPVlpqRHdLbEZSZDRsZVBGampQNDcyNXc3N0E5MGRTSGtEM05Lb01KTldXVXowNmhjT3JtZTNOUjRHSGZBMkZ4bTd5TDlpVlpyN0lCalR1X2Z5RWxRSDZxd0FGOUZ5NERXTEE1eWtFcFRoblNNaks4b2ZhYWJOWkhFMld4eExpUU1pRl80ZkFXekRkay1QUjljYkdxaVhIbVVra0FWc2pnTEZoV1hZNlpzZ1RxWHA3T2Jqd20tZEVxR2diZUw4R3gxZlQtd1RsS1NTUXI0YUVsZ0NDT2MzTVVnZmtqNGdRc1ZPZ3dsRVlrUQ?oc=5","date":"2026-03-04","type":"pipeline","source":"geneonline.com","summary":"Sino Biopharmaceutical Enters Exclusive Global Licensing Agreement with Sanofi for First-in-Class JAK/ROCK Inhibitor Rovadicitinib - geneonline.com","headline":"Sino Biopharmaceutical Enters Exclusive Global Licensing Agreement with Sanofi for First-in-Class JAK/ROCK Inhibitor Rov","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOYkQ3X0EwUUwxcHFRcnM5dmRscG9aYm5QNUZqN0pZX1EzRFd1SlQ4TU02bThFdTRleHUwUzdxMXhDb1hfb2JFS1lkR1UwcDNuZEh4dTVCektubDczc19KVFdhX2FDSlNkaFdaRjljQW9nUmpkTHlKWVJJS0QyTnBabGR6Y3FzdWs4MVdmQmxrMHVxQl9yYk9FWQ?oc=5","date":"2026-03-04","type":"deal","source":"BioWorld News","summary":"Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B - BioWorld News","headline":"Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQTFF5S0N3MDEyeGg3bUQ1UGNJa3BpeDN6aDJhckpERDNyTnJvSEJSX2o5cGtQREJGUllIY2dma0ozMDJla2ZWTUNQQ0lIelZDVFRJZXVqMjNMWWVQVDZ0cE9aM1JLckRNYW0yM0NOSjJ5aVpRbXZvSS1Rd2ZsdjRxdkx1anAtaVVSSXhSaUhpRGJoNFBHWlhoLUVub195WW01UTVDT3o1eGhQakx5bTVWckwyUk9kX2tydmNBa0Utd3JNZGJiTV9OU3NwdE9zblZ2RjhGVGtOc3dWX0pYaWZRTnc0WDdCZUk?oc=5","date":"2025-08-29","type":"regulatory","source":"Business Wire India","summary":"Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma - Business Wire India","headline":"Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-12-09","type":"pipeline","source":"The Chinese University of Hong Kong","summary":"CU Medicine and CTTQ sign a Cooperation Framework Agreement Leverage the strengths of mainland China and Hong Kong in pharmaceutical innovations, talent development & commercialisation of medical prod","headline":"CU Medicine and CTTQ sign a Cooperation Framework Agreement Leverage the strengths of mainland China and Hong Kong in ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPWE5sR1dWZW1pY011M2V3bFRYclpIbThsNW9WanluMXN4UGhVZVRnZ1RkVWNIbmtCdk5rUnJGZFFPZXhDZ08yb3ZVeXZlQ25iTTI0VVR1UE5wcnlBTjEtb3AwWEYxTEhzTjN1VUF1NHc2NlA4Z19aanhwZ2xZQVBMNjlld0twajBLWjQ5YU1Va2MtNmRNVFIzREc0aTRDUGNHR1AtNjhaZTdkdktDWjZVX2Y4VVRkcDJ5?oc=5","date":"2024-02-16","type":"trial","source":"Clinical Trials Arena","summary":"Inventiva halt recruitment for Phase III NASH trial following adverse event - Clinical Trials Arena","headline":"Inventiva halt recruitment for Phase III NASH trial following adverse event","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQTThpN19XbmNnRS16enZMMG5KZUhBbktkMVBsNGE0R0h4a2ZhbzQwQmRiQVJ5Z3JORUhrSlQwRlBuaV9Lc0RJV25ONTlmblBoYjdhaUhwU3JyMHMzOVcxRzZtRE9PZjh5YVZueU5PbEVZRWFpamNOZjVpYkd3MTBfc0xwbEN6VzBCUHVrOVczLWRhQWsxbUxWWkRXZWdKVS1fcFBJQWdMRXluWnVHNjdXT1UzMTNWVWVCN3RsV2M3TFZSLWZpZndZcHFVZG5xSHg5My12RHM4N1k2XzBmc3FaQ2Rnc1liTC1hRFJ5SVR5cHI?oc=5","date":"2023-08-22","type":"deal","source":"Business Wire","summary":"Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection - Business Wire","headline":"Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNcVBxb2xlaDBpT1RVWUZadHRsSlFHVE01aEFWMmhlYjdNWDJFcF9BcktNYndDbkxQQzZmM0ZFcjRVMTFiT0NzRlJKY3JHaVdvYy16dWpWckVtRnRPRGdmUGtpaTF5SElJWTVNN08zNXprYVRjaDBYeVEyclgwZE5sSUhES0MzUzdWb0Jha1V3VFZHV0FIRFljUGJFRnk4MmdxNWJPbl81WWFhd3Ffd3FZRkV4SHNlYUw0WU5NS1lzRmR3aFVUNUFqdThOTXM0N3ktSEhGNlN5cFc0RjlfaFdvWnlVcFJYcXJvWExpNXBIWDNRZkF2R2VQVmtR?oc=5","date":"2023-06-08","type":"pipeline","source":"Business Wire","summary":", (Enoxaparin Sodium – Preservative Free) in Prefilled Syringes - Business Wire","headline":", (Enoxaparin Sodium – Preservative Free) in Prefilled Syringes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOdmtVN1c2UnVYSzhvTUpPSEg0NXJWdmp0Q3UwLTJ0dFozY21LTXk2U2pZQ3VGNzdGTlhVOWZrZnppdl9Bc29xSndxOE5Sbm9yc2F2N3ZFUmd2NUVmX0g0ZzhvSE5JeWxLbTlmZ2dPVGUwWFB6bXlKOGdvMW8wd1h0QkJMVUhoRUNCQ0tOWE1GZjlrYnpKS19vcmpQUQ?oc=5","date":"2020-04-21","type":"pipeline","source":"openPR.com","summary":"Worldwide Report on Entecavir Market By Growing Sector with - openPR.com","headline":"Worldwide Report on Entecavir Market By Growing Sector with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOU0p2M29fRXhMSV9vY1ZqV1hDZmRNTEJBSk5LckxHX2d0RkQ2TjFkOTNfZWxSVWlBZV9TcDJEZV80MlB2N1pqcm5wc3NITXhfU2VHQ2taWWR0eHlsSS1oTWpMdXowcFFYc3ZoUmxKZGdZT1F0akp4cmFWbTZSYkRWRUNmc2pDRGF2Wl85ZHRJV1htalBacVZoaDktVQ?oc=5","date":"2019-06-20","type":"pipeline","source":"NAI500","summary":"Akeso Forms $100 Million JV with CTTQ to Develop PD-1 Candidate - NAI500","headline":"Akeso Forms $100 Million JV with CTTQ to Develop PD-1 Candidate - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQNUNTQ3EyYlJickhkRlBjNHhaNG10V3EzSEdxY2RIN0Z3VHBOM3RhdkpMZVpDaWVrOXN2MDVWMGJ5X0NCbHdUb0lGNjZaWkVJak1Bbm5MV1VhbUtyUE0wTTNZajlqX19qNDd6RFVwVlNSTjdhOE14d190OWhLbmh3NXR5ZlNLRElhNmprdHJwUE1wMkE4N1BFQlllcVVlcDBzLVVqTlhoa3ZfWDdwVEFWN1BJLTdReENjU1E?oc=5","date":"2016-01-07","type":"deal","source":"BioPharma Dive","summary":"Flurry of venture deals hits biopharma ahead of JPMorgan healthcare conference - BioPharma Dive","headline":"Flurry of venture deals hits biopharma ahead of JPMorgan healthcare conference","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}